Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
about
Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriersThe quest for non-invasive delivery of bioactive macromolecules: a focus on heparinsDesign and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates.Recent advances in search of oral heparin therapeutics.Strategies for enhanced peptide and protein delivery.
P2860
Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Zonula occludens toxin synthet ...... low molecular weight heparin.
@ast
Zonula occludens toxin synthet ...... low molecular weight heparin.
@en
type
label
Zonula occludens toxin synthet ...... low molecular weight heparin.
@ast
Zonula occludens toxin synthet ...... low molecular weight heparin.
@en
prefLabel
Zonula occludens toxin synthet ...... low molecular weight heparin.
@ast
Zonula occludens toxin synthet ...... low molecular weight heparin.
@en
P2093
P2860
P1476
Zonula occludens toxin synthet ...... low molecular weight heparin.
@en
P2093
Alessio Fasano
Bi-Botti C Youan
Mitchell S Wachtel
Nusrat A Motlekar
P2860
P304
P356
10.1080/10611860600613316
P577
2006-06-01T00:00:00Z